We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTUU
11151
DELISTED
Altitude Acquisition Corp Unit
ALTUU
$117K ﹤0.01%
11,720
-1,500
-11% -$15.1K
SNRHU
11152
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
$117K ﹤0.01%
11,816
-1
-0% -$10
AUD
11153
DELISTED
Audacy, Inc.
AUD
$117K ﹤0.01%
124,075
-262,251
-68% -$526K
PUCKU
11154
DELISTED
Goal Acquisitions Corp. Unit
PUCKU
$117K ﹤0.01%
11,794
ACVA icon
11155
PUT
ACV Auctions
ACVA
$1.4B
$116K ﹤0.01%
17,700
-39,100
-69% -$402K
BLND icon
11156
PUT
Blend Labs
BLND
$352M
$116K ﹤0.01%
49,300
+10,300
+26% +$38.5K
EOLS icon
11157
PUT
Evolus
EOLS
$539M
$116K ﹤0.01%
+10,000
New +$118K
VIP
11158
PUT
Vulcan Infrastructure and Power
VIP
$33.4M
$116K ﹤0.01%
4,573
-4,126
-47% -$232K
HDSN
11159
CALL
Hudson Technologies
HDSN
$239M
$116K ﹤0.01%
15,500
-8,100
-34% -$66.8K
MGTX icon
11160
CALL
MeiraGTx Holdings
MGTX
$1.3B
$116K ﹤0.01%
15,300
+2,700
+21% +$26.2K
MITK icon
11161
CALL
Mitek Systems
MITK
$877M
$116K ﹤0.01%
12,500
-23,600
-65% -$251K
MPX
11162
CALL
DELISTED
Marine Products Corp
MPX
$116K ﹤0.01%
12,200
-6,700
-35% -$74.1K
NGL icon
11163
NGL Energy Partners
NGL
$2.24B
$116K ﹤0.01%
76,450
-14,510
-16% -$28.5K
PDSB icon
11164
PDS Biotechnology
PDSB
$12.9M
$116K ﹤0.01%
31,917
-55,461
-63% -$264K
SGHC icon
11165
SGHC Ltd
SGHC
$6.76B
$116K ﹤0.01%
28,357
+13,928
+97% +$107K
VIRX
11166
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$116K ﹤0.01%
29,800
+1,900
+7% +$5.41K
PLXP
11167
CALL
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$116K ﹤0.01%
47,900
+12,700
+36% +$35.3K
CHAA.WS
11168
DELISTED
Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHAA.WS
$116K ﹤0.01%
1,050,089
-87
-0% -$17
GLSPU
11169
DELISTED
Global SPAC Partners Co. Unit
GLSPU
$116K ﹤0.01%
11,396
-390
-3% -$4.03K
RYM
11170
RYTHM Inc
RYM
$45.3M
$115K ﹤0.01%
20
-7
-26% -$59.5K
BHR
11171
CALL
Braemar Hotels & Resorts
BHR
$139M
$115K ﹤0.01%
26,900
-10,200
-27% -$57.6K
LOMA
11172
PUT
Loma Negra
LOMA
$1.1B
$115K ﹤0.01%
+22,600
New +$129K
SYRE icon
11173
Spyre Therapeutics
SYRE
$9.14B
$115K ﹤0.01%
9,088
+6,151
+209% +$216K
IDEX
11174
CALL
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$115K ﹤0.01%
1,394
+434
+45% +$39.1K
APEN
11175
CALL
DELISTED
Apollo Endosurgery, Inc.
APEN
$115K ﹤0.01%
31,500
-2,800
-8% -$13.2K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.